13F
← All fund report cards

Arete Wealth Advisors, LLC

13F equity value
$1.3B
Positions
329
Top 10 concentration
25.4%
Quarters / total new picks
32 / 1,215
13F equity value over time
$0M$614B$1.2T2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.8% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = -0.63, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-0.8%
t-stat
-0.63
Quarterly win rate
56%
Annualized excess
-3.4%
$1 → follow vs universe
$1.62 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.05920180630: follow 1.01120180930: follow 1.04720181231: follow 1.03420190331: follow 0.99020190630: follow 1.05820190930: follow 1.14820191231: follow 0.93020200331: follow 1.08120200630: follow 1.11220200930: follow 1.22220201231: follow 1.25820210331: follow 1.29220210630: follow 1.41920210930: follow 1.35320211231: follow 1.23420220331: follow 1.21320220630: follow 1.16220220930: follow 1.22820221231: follow 1.15420230331: follow 1.22920230630: follow 1.15920230930: follow 1.24920231231: follow 1.31120240331: follow 1.15820240630: follow 1.26620240930: follow 1.26920241231: follow 1.19720250331: follow 1.32120250630: follow 1.31120250930: follow 1.50620251231: follow 1.619 0.84 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 329 · 2026 Q1

Ticker Value Weight QoQ
JOB $45M
3.3%
NEW
SFBS $44M
3.3%
NEW
RSP $39M
2.9%
ADD
FBND $36M
2.7%
ADD
SPAB $35M
2.6%
ADD
NVDA $34M
2.5%
HOLD
PVAL $33M
2.4%
ADD
SPYM $27M
2.0%
ADD
VUG $25M
1.9%
ADD
EFV $23M
1.8%
TRIM
GLD $23M
1.7%
ADD
JNJ $20M
1.5%
ADD
PULS $19M
1.4%
ADD
SPY $18M
1.4%
ADD
MSFT $18M
1.3%
TRIM
AAPL $17M
1.3%
TRIM
AQST $14M
1.1%
NEW
SPTM $14M
1.0%
ADD
XOM $13M
1.0%
TRIM
BIL $12M
0.9%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.